Clinical trends in atrial fibrillation at the turn of the millenium

Journal of Internal Medicine

Volumn 250, Issue 5, 2001, Pages 369-372

  Savelieva, I ^a   Camm, A John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET; DISEASE ASSOCIATION; EDITORIAL; FOLLOW UP; GENETIC PREDISPOSITION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; MORBIDITY; MORTALITY; NONHUMAN; PATHOLOGY; POPULATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; STROKE;

ADULT; AGE DISTRIBUTION; AGED; ATRIAL FIBRILLATION; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 0034777261     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00908.x     Document Type: Editorial

References (15)

1. Incidence of and risk factors for atrial fibrillation in older adults
2. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham heart study
3. Impact of atrial fibrillation on risk of death: The Framingham study
4. Atrial fibrillation as independent risk factor for stroke: The Framingham study
5. Hospitalization for arrhythmias in the United States. Importance of atrial fribrillation
6. Secular trends in the prevalence of atrial fibrillation: The Framingham study
7. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996
8. Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980-1993
9. Newly diagnosed atrial fibrillation and acute stroke: The Framingham study
10. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
11. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke prevention in atrial fibrillation III investigators
12. The multifactor primary prevention trial in Göteborg, Sweden
13. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study
14. Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience
15. Identification of a genetic locus for familial atrial fibrillation